Homocysteine, B vitamins, and cardiovascular disease (correspondence)

NEJM correspondence on HOPE-2 and related trials

PRIMÄR Tier 2 2006

StudiedesignPRIMÄR

TierTier 2, Strong human evidence, hard endpoints or biomarkers

År2006

TidskriftNew England Tidskrift of Medicine

Tillagd i NO1GEVITYjun 2, 2026

Citerad av

1 encyklopediartiklar refererar till denna studie.